Current Issue: May 2025
Feature
From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis
Abstract: Within the evolving landscape of eosinophilic esophagitis (EoE) management are multiple pharmacologic treatment modalities, including proton pump inhibitors (PPIs), swallowed topical corticosteroids, and novel biologic […]
Feature
Looking Toward the Future: Emerging Therapies for Hepatocellular Carcinoma
Abstract: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide. Despite the decreasing prevalence of hepatitis C, the burden of HCC is expected to […]
Letter From the Editor
Letter From the Editor: Exploring the Use of Digital Therapeutics for Patients With Disorders of Gut-Brain Interaction
Can digital therapeutics such as apps help in the management of patients with disorders of gut-brain interaction? This question is explored in the Advances in IBS […]
Advances in IBD
Insights Into Cell Therapies for Patients With Inflammatory Bowel Disease
G&H Why has there been interest in using cell therapies to treat patients with inflammatory bowel disease? LC For a long time, it seemed like it […]
Advances in Hepatology
Update on the Management of Cholestatic Pruritus
G&H Why is cholestatic pruritus important, and how can it affect patients? KB Cholestatic pruritus, or itch, is important because it affects the majority of patients […]
HCC in Focus
Highlights From the Recent APASL Guidelines on Systemic Therapy for Hepatocellular Carcinoma
G&H Why were guidelines recently released by the Asian Pacific Association for the Study of the Liver on systemic therapy for patients with hepatocellular carcinoma? GL […]
Advances in Endoscopy, Esophageal cancer, NASH
Missing the Mark: Optimizing Endoscopy for Intestinal Metaplasia and Gastric Cancer Detection in the United States
G&H What is the risk of gastric cancer relative to that of colorectal cancer worldwide and in the United States? JHH Colorectal cancer, broadly speaking, affects […]
Advances in IBS
The Promise of Digital Therapeutics for Disorders of Gut-Brain Interaction
G&H Why is it important to address unhealthy behavior patterns in patients with disorders of gut-brain interaction? What are the main targets for intervention? KS Typically, […]
Supplements:
Patient-Centered Approach in IBS-C Management
About the Patient CS is a 40-year-old female internist who was referred to my clinic by a colorectal surgeon in February 2025. CS had consulted the […]